Published online before print January 23, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
Department of Biochemistry and Molecular Genetics, University of Virginia Health System, Charlottesville
@ To whom correspondence should be addressed. E-mail: jss5y{at}virginia.edu.
The silent information regulator (Sir2) family of protein deacetylases (Sirtuins) are nicotinamide adenine dinucleotide (NAD)+-dependent enzymes that hydrolyze one molecule of NAD+ for every lysine residue that is deacetylated. The Sirtuins are phylogenetically conserved in eukaryotes, prokaryotes, and Archeal species. Prokaryotic and Archeal species usually have one or two Sirtuin homologs, whereas eukaryotes typically have multiple versions. The founding member of this protein family is the Sir2 histone deacetylase of Saccharomyces cerevisiae, which is absolutely required for transcriptional silencing in this organism. Sirtuins in other organisms often have nonhistone substrates and in eukaryotes, are not always localized in the nucleus. The diversity of substrates is reflected in the various biological activities that Sirtuins function, including development, metabolism, apoptosis, and heterochromatin formation. This review emphasizes the great diversity in Sirtuin function and highlights its unusual catalytic properties.
Key Words: Sirtuin • NAD+ • S. cerevisiae • silencing
This article has been cited by other articles:
 |
|
 |
|
  M. R. Koch and L. Pillus From the Cover: The glucanosyltransferase Gas1 functions in transcriptional silencing PNAS, July 7, 2009; 106(27): 11224 - 11229. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Altman-Price and M. Mevarech Genetic Evidence for the Importance of Protein Acetylation and Protein Deacetylation in the Halophilic Archaeon Haloferax volcanii J. Bacteriol., March 1, 2009; 191(5): 1610 - 1617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pons, F. R. de Vries, P. J. van den Elsen, B. T. Heijmans, P. H.A. Quax, and J. W. Jukema Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease Eur. Heart J., February 1, 2009; 30(3): 266 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. Kazantsev and A. M. Kolchinsky Central Role of {alpha}-Synuclein Oligomers in Neurodegeneration in Parkinson Disease Arch Neurol, December 1, 2008; 65(12): 1577 - 1581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Buelow, Y. Song, and A. M. Scharenberg The Poly(ADP-ribose) Polymerase PARP-1 Is Required for Oxidative Stress-induced TRPM2 Activation in Lymphocytes J. Biol. Chem., September 5, 2008; 283(36): 24571 - 24583. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Fournel, C. Bonfils, Y. Hou, P. T. Yan, M.-C. Trachy-Bourget, A. Kalita, J. Liu, A.-H. Lu, N. Z. Zhou, M.-F. Robert, et al. MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo Mol. Cancer Ther., April 1, 2008; 7(4): 759 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. K. Shwab, J. W. Bok, M. Tribus, J. Galehr, S. Graessle, and N. P. Keller Histone Deacetylase Activity Regulates Chemical Diversity in Aspergillus Eukaryot. Cell, September 1, 2007; 6(9): 1656 - 1664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S Parihar and G. J. Brewer Mitoenergetic failure in Alzheimer disease Am J Physiol Cell Physiol, January 1, 2007; 292(1): C8 - C23. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Morrison, N. Majdzadeh, X. Zhang, A. Lyles, R. Bassel-Duby, E. N. Olson, and S. R. D'Mello Neuroprotection by Histone Deacetylase-Related Protein Mol. Cell. Biol., May 1, 2006; 26(9): 3550 - 3564. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tribus, J. Galehr, P. Trojer, G. Brosch, P. Loidl, F. Marx, H. Haas, and S. Graessle HdaA, a Major Class 2 Histone Deacetylase of Aspergillus nidulans, Affects Growth under Conditions of Oxidative Stress Eukaryot. Cell, October 1, 2005; 4(10): 1736 - 1745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kaeberlein, T. McDonagh, B. Heltweg, J. Hixon, E. A. Westman, S. D. Caldwell, A. Napper, R. Curtis, P. S. DiStefano, S. Fields, et al. Substrate-specific Activation of Sirtuins by Resveratrol J. Biol. Chem., April 29, 2005; 280(17): 17038 - 17045. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Fox and K. H. McConnell Toward Biochemical Understanding of a Transcriptionally Silenced Chromosomal Domain in Saccharomyces cerevisiae J. Biol. Chem., March 11, 2005; 280(10): 8629 - 8632. [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Barnes, I. M. Adcock, and K. Ito Histone acetylation and deacetylation: importance in inflammatory lung diseases Eur. Respir. J., March 1, 2005; 25(3): 552 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Freeman-Cook, E. B. Gomez, E. J. Spedale, J. Marlett, S. L. Forsburg, L. Pillus, and P. Laurenson Conserved Locus-Specific Silencing Functions of Schizosaccharomyces pombe sir2+ Genetics, March 1, 2005; 169(3): 1243 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Araki, Y. Sasaki, and J. Milbrandt Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration Science, August 13, 2004; 305(5686): 1010 - 1013. [Abstract] [Full Text] [PDF]
|
|
